Renal cell carcinoma (RCC) is distinguished by its varied metabolic reprogramming driven by tumor suppressor gene dysregulation and oncogene activation. Tumors can adapt nutrient uptake and metabolism pathways to meet the altered biosynthetic, bioenergetic and redox demands of cancer cells, whereas conventional chemotherapeutics and molecular inhibitors predominantly target individual metabolic pathways without addressing this adaptability. Flavonoids, which are well‑known for their antioxidant and anti‑inflammatory properties, offer a unique approach by influencing multiple metabolic targets. The present comprehensive review reveals the intricate processes of RCC metabolic reprogramming, encompassing glycolysis, mitochondrial oxidative phosphorylation and fatty acid biosynthesis. The insights derived from the present review may contribute to the understanding of the specific anticancer mechanisms of flavonoids, potentially paving the way for the development of natural antitumor drugs focused on the metabolic reprogramming of RCC.

The kidney plays a crucial role in regulating homeostasis within the human body. Renal cell carcinoma (RCC) is the most common form of kidney cancer, accounting for nearly 90 % of all renal malignancies. Despite the availability of various therapeutic strategies, RCC remains a challenging disease due to its resistance to conventional treatments. Nanotechnology has emerged as a promising field, offering new opportunities in cancer therapeutics. It presents several advantages over traditional methods, enabling diverse biomedical applications, including drug delivery, prevention, diagnosis, and treatment. Lipid nanoparticles (LNPs), approximately 100 nm in size, are derived from a range of lipids and other biochemical compounds. these particulates are designed to overcome biological barriers, allowing them to selectively accumulate at diseased target sites for effective therapeutic action. Many pharmaceutically important compounds face challenges such as poor solubility in aqueous solutions, chemical and physiological instability, or toxicity. LNP technology stands out as a promising drug delivery system for bioactive organic compounds. This article reviews the applications of LNPs in RCC treatment and explores their potential clinical translation, identifying the most viable LNPs for medical use. With ongoing advancement in LNP-based anticancer strategies, there is a growing potential to improve the management and treatment of renal cancer.

Hyperhidrosis, a condition of excessive sweat generation, is believed to be genetic, but it is yet not known well whether primary hyperhidrosis is regulated by a single gene or multiple genes. The prospective genes that regulate primary hyperhidrosis are known to be ITPR2, TMEM16A, FOXA1 and AQP5. Of these four genes, ITPR2 gene plays a significant role in primary hyperhidrosis; thus in the current research sequence, analysis of this gene was carried out. Following inclusion and exclusion criteria, whole blood samples were taken from four patients inflicted with primary hyperhidrosis and two from healthy persons as control. From the blood samples, white blood cells were separated by reacting the samples with ammonium chloride (NH4Cl) solution to lyse red blood cells. Then total RNA was extracted using the trizol reagent. For synthesizing cDNA, one script reverse transcriptase cDNA synthesis kit was employed. The cDNA samples were quantified using a Qubit Flourometer and their quality was appraised on agarose gel. Real time PCR was performed to carry out the quantitative analysis of these four genes. Of four genes, the expression of three genes, i.e., TMEM16A, ITPR2 and FOXA1, was found to be significantly high in the primary hyperhidrosis patients, whereas low expression of the gene AQP5 was noted compared to that of the control samples. Microarray data analysis on anhidrosis was done using GEO2R database as well as the anhidrosis datasets available on Gene Exression Omnibus (GEO). From this analysis, the low expression of FOXA1 in anhidrosis was confirmed. Based on the highest expression of ITPR2 in hyperhidrosis, it was selected for PCR amplification as well as sequencing. The sequence analysis of ITPR2 showed 100% identity without any mutation.These key genes will further help us to devise new treatment modalities.

Ankylosing spondylitis is a chronic inflammatory rheumatic disease that primarily affects the axial skeleton, resulting in back pain and progressive stiffness. The purpose of this study is to provide an integrated observation in the form of pathophysiology, clinical criteria, and available medical methods. Environmental factors and genetic susceptibility, mainly HLA-B27, are an intricate interaction in AS Etiology. Increased knowledge about immunopathogenesis has added the role of pro-inflammatory cytokines such as IL-17 and TNF-α in the devastating course of the disease. Early diagnosis is indicated but immensely challenging, as the onset is gradual and presenting symptoms are futile. MRI and other radiographic imaging, along with genetic workup and biomarkers, are of most significance in initial identification. With advances in biological therapies with the potential to block various inflammatory cascades, there is hope of improved outcomes and quality of life in patients. Non-pharmacological management in the guise of physiotherapy and lifestyle modification continues to be an integral part of the comprehensive management plan. The review also references the necessity of utilizing a multidisciplinary approach in optimizing patient outcomes in the context of recent advances in the etiology and treatment of AS.

Rhinoplasty is one of the most commonly performed aesthetic surgical procedures in plastic surgery. Over the past 20 years, one of the most gratifying operations performed by facial plastic surgeons remains rhinoplasty. Both surgeries and patients may feel like they are running "home" when everything is running as scheduled, but mutual sadness may also occur when the outcome is different. Many of the typical complexities can be prevented with careful attention to particular operational maneuvers with intentional actions, extra grafts, or more conservative resections during the main rhino-plastic procedure. A view of these retrospective problems may reveal typical risks that are preemptive when the procedure is performed. Due to the subjective character of the esthetic outcome, the identification of problems in cosmetic rhinoplasty is challenging. One may expect rhino-plastic patients more critical of the outcomes, but our experience as well as those of others suggest that the surgeon is more likely than the patient to be satisfied. With a subsequent medial collapse, the ULCs might become destabilized. Moreover, the new dorsal septum produced by the excision of the hump is smaller than the original native dorsum. Even if the ULCs shrink solidly to the septum, a constricted middle vault region will be created.